Tortugas Neuroscience Secures $106M for Neurological Disorder Therapies
β’ Framingham, MA-based Tortugas Neuroscience raised $106 million in combined seed and Series A funding for small molecule therapies targeting neurological disorders. β’ Cure Ventures led the seed round, with The Column Group and AN Venture Partners co-leading Series A on April 21. β’ The investment accelerates development of treatments using validated biological targets, addressing unmet needs in US biotech.
Read original Β· cryptoniteventures.substack.com
Cryptonite Ventures




